- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00765167
Training and Calibration of Dental Examiners
October 2, 2008 updated by: Colgate Palmolive
Training and calibration of dental examiners
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Newark, New Jersey, United States, 07101
- UMDNJ Dental School
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female volunteers 18-65 years of age
- Good general health
- Must sign informed consent form
- Minimum of 20 natural uncrowned teeth (excluding third molars) must be present.
- No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.
Exclusion Criteria:
- Subjects unable or unwilling to sign the informed consent form.
- Medical condition which requires pre-medication prior to dental visits/procedures
- Moderate or advanced periodontal disease or heavy dental tartar (calculus).
- 2 or more decayed untreated dental sites at screening.
- Other disease of the hard or soft oral tissues.
- Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).
- Use of medications that can affect salivary flow (e.g. anticholinergics, adrenergics, antihistamines, vasoconstrictors or decongestants).
- Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1.
- Pregnant or nursing women.
- Participation in any other clinical study within 1 week prior to enrollment into this study.
- Allergy to chlorhexidine
- Use of tobacco products
- Subjects who must receive dental treatment during the study dates.
- Current use of Antibiotics for any purpose.
- Presence of an orthodontic appliance.
- History of allergy to common dentifrice ingredients.
- Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: B
|
Brush half mouth twice daily for four days
Brush half mouth daily for four days
Brush half mouth daily for four days
|
Active Comparator: C
|
Mouth rinsing with 15 ml for 30 seconds twice a day for four days
|
Placebo Comparator: A
|
Brush half mouth twice daily for four days
Brush half mouth daily for four days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Dental plaque
Time Frame: 6 weeks
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael Deasy, DDS
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2007
Primary Completion (Actual)
December 1, 2007
Study Completion (Actual)
December 1, 2007
Study Registration Dates
First Submitted
September 23, 2008
First Submitted That Met QC Criteria
September 30, 2008
First Posted (Estimate)
October 2, 2008
Study Record Updates
Last Update Posted (Estimate)
October 3, 2008
Last Update Submitted That Met QC Criteria
October 2, 2008
Last Verified
October 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Stomatognathic Diseases
- Tooth Diseases
- Dental Deposits
- Dental Plaque
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents, Local
- Anti-Infective Agents
- Antimetabolites
- Protective Agents
- Dermatologic Agents
- Hypolipidemic Agents
- Lipid Regulating Agents
- Cariostatic Agents
- Disinfectants
- Fatty Acid Synthesis Inhibitors
- Fluorides
- Chlorhexidine
- Chlorhexidine gluconate
- Triclosan
Other Study ID Numbers
- ATO-2007-PLA-01-RR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Plaque
-
Azienda Ospedaliera Città della Salute e della...Recruiting
-
Colgate PalmoliveCompleted
-
Church & Dwight Company, Inc.Completed
-
Damascus UniversityCompletedPlaque, DentalSyrian Arab Republic
-
Church & Dwight Company, Inc.Completed
-
Church & Dwight Company, Inc.CompletedPlaque, DentalUnited States
-
Colgate PalmoliveCompleted
-
Multan Medical And Dental CollegeUnknown
-
Marmara UniversityCompletedPlaque, DentalTurkey
-
Heba sabbaghCompleted
Clinical Trials on Fluoride
-
Procter and GambleCompleted
-
GlaxoSmithKlineCompletedOral HygieneUnited States
-
Khon Kaen UniversityCompletedQuality of Life | Dental Caries in Children | Satisfaction | Oral Health | Cost EffectivenessThailand
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloUnknown
-
University of MichiganEnrolling by invitationDental CariesUnited States
-
Advantage Dental Services, LLCCompleted
-
GlaxoSmithKlineCompleted
-
Frank LippertThe Borrow FoundationCompleted
-
GlaxoSmithKlineCompleted
-
Federal University of ParaíbaConselho Nacional de Desenvolvimento Científico e Tecnológico; Coordination...Completed